FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
GUAIFENESIN; CODEINE PHOSPHATE | 55154-5791-5 | Cardinal Health 107, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE | 43378-124-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 70861-1107-1 | Bishop Pharma, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
GUAIFENESIN; CODEINE PHOSPHATE | 71205-624-04 | Proficient Rx LP | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE | 58605-303-16 | MCR American Pharmaceuticals, Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 70752-177-06 | QUAGEN PHARMACEUTICALS LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 50436-2520-1 | Unit Dose Services | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
GUAIFENESIN; CODEINE PHOSPHATE | 17856-0500-5 | ATLANTIC BIOLOGICALS CORP. | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CODEINE PHOSPHATE; GUAIFENESIN | 57963-103-16 | The Generic Pharmaceutical Company | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
PYRILAMINE MALEATE; CODEINE PHOSPHATE | 66594-333-01 | Pro-Pharma LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 58657-500-16 | Method Pharmaceuticals, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 69367-272-04 | Westminster Pharmaceuticals, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CODEINE PHOSPHATE; GUAIFENESIN | 0121-1775-00 | Pharmaceutical Associates, Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 0682-0475-16 | Marnel Pharmaceuticals, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 16571-302-16 | Rising Pharmaceuticals | HUMAN OTC DRUG | UNAPPROVED DRUG OTHER | |
GUAIFENESIN; CODEINE PHOSPHATE | 50383-087-05 | Akorn Operating Company LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 68788-8361-1 | Preferred Pharmaceuticals Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; CODEINE PHOSPHATE | 66594-333-16 | Pro-Pharma LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 60575-414-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 50383-087-16 | Akorn Operating Company LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 70752-180-12 | QUAGEN PHARMACEUTICALS LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 63187-117-04 | Proficient Rx LP | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; CODEINE PHOSPHATE | 50090-0423-0 | A-S Medication Solutions | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CODEINE PHOSPHATE; GUAIFENESIN | 54932-208-81 | BioRamo, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE | 60575-313-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 69315-248-48 | Leading Pharma, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 57963-103-04 | The Generic Pharmaceutical Company | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
GUAIFENESIN; CODEINE PHOSPHATE | 12634-969-04 | Apotheca, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 70752-180-15 | QUAGEN PHARMACEUTICALS LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 21695-421-04 | Rebel Distributors Corp. | part341 | HUMAN OTC DRUG | OTC monograph final |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-762 |
-